Smaller pharmaceutical firms to hit hardest by government’s price cut plan

A chief executive of one of the smaller drug-making companies in Korea expressed concern about the country’s pharmaceutical industry.

“The recent legal action by two small drug makers reflects their urgency for survival as the Korean pharmaceutical industry awaits a policy to slash drug prices in April.

All local drug makers are the focus of the government policy. However, the smaller dru...